| Literature DB >> 29430535 |
Sennay A Gebremariam1, Hannah S Yang2,3.
Abstract
BACKGROUND: Stroke is becoming an increasingly serious public health issue in Ethiopia and the paucity of data specific to the Ethiopian setting is limiting the formulation of an appropriate response.Entities:
Keywords: Cerebrovascular accident; Epidemiology; Ethiopia; Hospital; Medical record review; Stroke
Year: 2016 PMID: 29430535 PMCID: PMC5803092 DOI: 10.1016/j.ensci.2016.02.010
Source DB: PubMed Journal: eNeurologicalSci ISSN: 2405-6502
Demographic characteristics and risk factor profile by stroke subtype.
| All patients (n = 142) | Ischemic (n = 79) | Transient ischemic attack (n = 2) | Sub-arachnoid hemorrhage (n = 8) | Intra-cerebral hemorrhage (n = 46) | Other stroke (n = 7) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 25 | 3 | 2.1% | 2 | 2.5% | 0 | 0 | 1 | 2.2% | 0 | |||
| 25–44 | 14 | 9.9% | 5 | 6.3% | 1 | 50.0% | 1 | 12.5% | 6 | 13.0% | 1 | 14.3% |
| 45–64 | 47 | 33.1% | 24 | 30.4% | 0 | 4 | 50.0% | 17 | 37.0% | 2 | 28.6% | |
| 65–84 | 71 | 50.0% | 42 | 53.2% | 1 | 50.0% | 3 | 37.5% | 21 | 45.6% | 4 | 57.1% |
| > 85 | 7 | 4.9% | 6 | 7.6% | 0 | 0 | 1 | 2.2% | 0 | |||
| Male | 77 | 54.2% | 44 | 55.7% | 1 | 50.0% | 4 | 50.0% | 16 | 34.8% | 0 | |
| Female | 65 | 45.8% | 35 | 44.3% | 1 | 50.0% | 4 | 50.0% | 30 | 65.2% | 7 | 100% |
| Urban | 84 | 59.2% | 46 | 58.2% | 2 | 100% | 8 | 100% | 23 | 50.0% | 5 | 71.4% |
| Rural | 58 | 40.8% | 33 | 41.8% | 0 | 0 | 23 | 50.0% | 2 | 28.6% | ||
| Hypertension only | 49 | 34.5% | 16 | 20.3% | 1 | 50.0% | 6 | 75.0% | 20 | 43.5% | 6 | 85.7% |
| Diabetes only | 2 | 1.4% | 2 | 2.5% | 0 | 0 | 0 | 0 | ||||
| HTN & diabetes | 5 | 3.5% | 2 | 2.5% | 0 | 0 | 3 | 6.5% | 0 | |||
| Unable to determine | 86 | 60.6% | 59 | 74.7% | 1 | 50.0% | 2 | 25.0% | 23 | 50.0% | 1 | 14.3% |
Clinical presentation at hospital arrival by stroke subtype.
| All patients (n = 142) | Ischemic (n = 79) | Transient ischemic attack (n = 2) | Sub-arachnoid hemorrhage (n = 8) | Intra-cerebral hemorrhage (n = 46) | Other stroke (n = 7) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Focal neurologic deficit | 94 | 67.6% | 56 | 70.9% | 1 | 50.0% | 6 | 75.0% | 26 | 56.5% | 5 | 71.4% |
| Coma or altered mentation | 8 | 5.8% | 1 | 1.3% | 0 | 0 | 7 | 15.2% | ||||
| Both FND and CAM | 37 | 26.6% | 21 | 26.6% | 1 | 50.0% | 1 | 12.5% | 12 | 26.1% | 2 | 28.6% |
| No symptoms recorded | 3 | 2.1% | 1 | 1.3% | 0 | 1 | 12.5% | 1 | 2.2% | |||
| ≤ 89 mm Hg | 1 | 0.7% | 1 | 1.3% | 0 | 0 | 0 | 0 | ||||
| Normal range 90–120 mm Hg | 37 | 26.1% | 31 | 39.3% | 1 | 50.0% | 0 | 4 | 8.7% | 1 | 14.3% | |
| 121–139 mm Hg | 8 | 5.6% | 5 | 6.3% | 0 | 0 | 3 | 6.5% | 0 | |||
| ≥ 140 mm Hg | 94 | 66.2% | 40 | 50.6 | 1 | 50.0% | 8 | 100% | 39 | 84.8% | 6 | 85.7% |
| Unable to determine | 2 | 1.4% | 2 | 2.5% | 0 | 0 | 0 | 0 | ||||
| ≤ 59 bpm | 6 | 4.2% | 3 | 3.8% | 0 | 0 | 3 | 6.5% | 0 | |||
| Normal 60–100 bpm | 117 | 82.4% | 63 | 79.8% | 2 | 100% | 8 | 100% | 38 | 82.6% | 6 | 85.7% |
| 101–129 bpm | 16 | 11.3% | 11 | 13.9% | 0 | 0 | 4 | 8.7% | 1 | 14.3% | ||
| Unable to determine | 3 | 2.1% | 2 | 2.5% | 0 | 0 | 1 | 2.2% | 0 | |||
| Normal (12–20/min) | 54 | 38.0% | 32 | 40.5% | 1 | 50.0% | 2 | 25.0% | 17 | 37.0% | 2 | 28.6% |
| ≥ 21/min | 85 | 59.9% | 45 | 57.0% | 1 | 50.0% | 6 | 75.0% | 28 | 60.8% | 5 | 71.4% |
| Unable to determine | 3 | 2.1% | 2 | 2.5% | 0 | 0 | 1 | 2.2% | 0 | |||
| Regular | 41 | 28.9% | 22 | 27.9% | 0 | 5 | 62.5% | 10 | 21.7% | 4 | 57.1% | |
| Atrial fibrillation | 11 | 7.7% | 9 | 11.4% | 0 | 0 | 2 | 4.4% | 0 | |||
| Unable to determine | 90 | 63.4% | 48 | 60.7% | 2 | 100% | 3 | 37.5% | 34 | 73.9% | 3 | 42.9% |
Treatments, complications, and prognosis by stroke subtype.
| All patients (n = 142) | Ischemic (n = 79) | Transient ischemic attack (n = 2) | Sub-arachnoid hemorrhage (n = 8) | Intra-cerebral hemorrhage (n = 46) | Other stroke (n = 7) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aspirin | 84 | 59.2% | 74 | 93.7% | 1 | 50.0% | 1 | 12.5% | 5 | 10.9% | 3 | 42.9% |
| Anti-HTN | 87 | 61.3% | 36 | 45.6% | 2 | 100% | 7 | 87.5% | 38 | 82.6% | 4 | 57.1% |
| Anti-coagulant | 37 | 26.1% | 25 | 31.7% | 1 | 50.0% | 1 | 12.5% | 8 | 17.4% | 2 | 28.6% |
| Anti-convulsant | 22 | 15.5% | 11 | 13.9% | 2 | 25% | 8 | 17.4% | 1 | 14.3% | ||
| Diuretic | 22 | 15.5% | 7 | 8.9% | 1 | 12.5% | 12 | 26.1% | 2 | 28.6% | ||
| Laxative | 8 | 5.6% | 5 | 6.3% | 3 | 6.5% | ||||||
| Statin | 36 | 25.4% | 31 | 39.2% | 1 | 12.5% | 3 | 6.5% | 1 | 14.3% | ||
| Anti-biotic | 32 | 22.5% | 11 | 13.9% | 3 | 37.5% | 15 | 32.6% | 3 | 42.9% | ||
| Pain | 23 | 16.2% | 8 | 10.1% | 2 | 25.0% | 11 | 23.9% | 2 | 28.6% | ||
| Intracranial hemorrhage | 21 | 14.8% | 2 | 2.5% | 3 | 37.5% | 16 | 34.8% | ||||
| Seizure | 14 | 9.9% | 6 | 7.6% | 1 | 50.0% | 1 | 12.5% | 4 | 8.7% | 2 | 28.6% |
| Infection | 30 | 21.1% | 15 | 19.0% | 1 | 50.0% | 1 | 12.5% | 10 | 21.7% | 3 | 42.9% |
| Increased ICP | 27 | 26.1% | 16 | 20.3% | 1 | 12.5% | 16 | 34.8% | 4 | 57.1% | ||
| Other serious complications | 40 | 28.2% | 21 | 26.6% | 1 | 50.0% | 3 | 37.5% | 12 | 26.1% | 3 | 42.9% |
| Inpatient mortality | 17 | 12.0% | 6 | 7.6% | 2 | 25.0% | 7 | 15.2% | 2 | 28.6% | ||
| Left against medical advice | 29 | 20.4% | 17 | 21.5% | 1 | 12.5% | 11 | 23.9% | ||||
| Improved | 68 | 47.9% | 40 | 50.6% | 2 | 100% | 5 | 62.5% | 20 | 43.5% | 1 | 14.3% |
| Referred | 6 | 4.2% | 4 | 5.1% | 2 | 28.6% | ||||||
| Unable to determine | 22 | 15.5% | 12 | 15.2% | 8 | 17.4% | 2 | 28.6% | ||||